Filter posts

New York Legislators to PTO Head: Stop IPR Abuse

This week ten members the U.S. House of Representatives from New York wrote to U.S. …

Now What is Patentable?

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the …

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase …

Milwaukee Journal Sentinel Story on Use of Surrogate Measures

Earlier this week, John Fauber of the Milwaukee Journal Sentinel wrote an article on measures …

Patent Cases Down by 40% in 2014

The number of new patent cases filed in federal court has dropped by an astonishing …

Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story

This week, the Center for Medicine in the Public Interest issued a press release criticizing …

Tony Coelho: A Patient Advocate's Perspective on Paying for Value

Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized

Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical …

BIO Urges Comprehensive Tax Reform

Earlier this week, the Treasury Department issued a notice of its intent to propose rules …